Importer of Controlled Substances Application: PerkinElmer, Inc., 9337-9338 [2018-04407]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 43 / Monday, March 5, 2018 / Notices
(updating metadata, performing well
maintenance, and well drilling). The
proposal would also require estimates of
costs to complete the above tasks and a
timeline for planned completion. The
proposal will be reviewed by the USGS
and the NGWMN Program Board who
will make funding recommendations.
Title of Collection: National GroundWater Monitoring Network Cooperative
Funding Application.
OMB Control Number: 1028–0114.
Form Number: None.
Type of Review: Extension of a
currently approved collection.
Respondents/Affected Public: Multistate, state, or local water-resources
agencies who operate groundwater
monitoring networks.
Total Estimated Number of Annual
Respondents: 30.
Total Estimated Number of Annual
Responses: 30.
Estimated Completion Time per
Response: 40 hours.
Total Estimated Number of Annual
Burden Hours: 1200 hours.
Respondent’s Obligation: Mandatory
to be considered for funding.
Frequency of Collection: Annually.
Total Estimated Annual Non-hour
Burden Cost: None.
An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
The authorities for this action are the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501, et seq.).
Janice M. Fulford,
Director Observing Systems Division.
[FR Doc. 2018–04396 Filed 3–2–18; 8:45 am]
BILLING CODE 4338–11–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–895 (Third
Review)]
sradovich on DSK3GMQ082PROD with NOTICES
Pure Granular Magnesium From China;
Determination
On the basis of the record 1 developed
in the subject five-year review, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
antidumping duty order on pure
granular magnesium from China would
be likely to lead to continuation or
recurrence of material injury to an
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Sep<11>2014
19:25 Mar 02, 2018
Jkt 244001
industry in the United States within a
reasonably foreseeable time.
Background
The Commission, pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)),
instituted this review on September 1,
2017 (82 FR 41651) and determined on
December 5, 2017 that it would conduct
an expedited review (83 FR 4269,
January 30, 2018).
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on February 27, 2017. The
views of the Commission are contained
in USITC Publication 4761 (February
2018), entitled Pure Granular
Magnesium from China: Investigation
No. 731–TA–895 (Third Review).
By order of the Commission.
Issued: February 27, 2018.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2018–04332 Filed 3–2–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Stepan Company
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 4, 2018. Such persons
may also file a written request for a
hearing on the application on or before
April 4, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
DATES:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
9337
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on January
17, 2018, Stepan Company, Natural
Products Department, 100 W Hunter
Avenue, Maywood, NJ 07607 applied to
be registered as an importer of coca
leaves (9040), a basic class of controlled
substance listed in Schedule II.
The company plans to import the
listed controlled substance in bulk for
the manufacture of controlled
substances for distribution to its
customers.
Dated: February 26, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–04406 Filed 3–2–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: PerkinElmer, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 4, 2018. Such persons
may also file a written request for a
hearing on the application on or before
April 4, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
DATES:
E:\FR\FM\05MRN1.SGM
05MRN1
9338
Federal Register / Vol. 83, No. 43 / Monday, March 5, 2018 / Notices
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
November 15, 2017, PerkinElmer, Inc.,
549 Albany Street, Boston, MA 02118
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Thebaine ...................
Lysergic acid
diethylamide.
Drug
code
Schedule
9333
7315
II
I
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2018–04407 Filed 3–2–18; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
19:25 Mar 02, 2018
Jkt 244001
Notice of Lodging of Proposed
Amendment to Consent Decree Under
the Clean Water Act
On February 26, 2018, the Department
of Justice lodged a proposed second
amendment to a consent decree with the
United States District Court for the
Eastern District of Missouri in the
lawsuit entitled in United States, et al.
v. Metropolitan St. Louis Sewer District,
Civil Action No. 4:07–CV–01120.
Under the original 2012 consent
decree, the Metropolitan St. Louis
Sewer District (‘‘MSD’’) agreed to
undertake numerous measures to come
into compliance with the Clean Water
Act, including constructing three CSO
storage tunnels and a CSO treatment
unit. MSD still is in the process of
complying with the 2012 decree. The
proposed amendment would extend the
deadlines for completing the three CSO
storage tunnels and treatment unit by an
additional three to seven years. The
final compliance deadline for all CSO
control measures will be extended by
five years from June 30, 2034 to June 30,
2039.
The publication of this notice opens
a period of public comment on the
proposed amendment. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States, et al. v.
Metropolitan St. Louis Sewer District,
D.J. Ref. No. 90–5–1–1–08111. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
The company plans to import the
listed controlled substances in bulk for
manufacturing wherein the controlled
substances will be labeled with a
radioactive tracer compound and sold
for research purposes to its customers.
Thebaine (9333) will be used to
manufacture the derivative
Diprenorphine.
Dated: February 26, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
cost) payable to the United States
Treasury.
DEPARTMENT OF JUSTICE
Send them to:
By e-mail ......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
During the public comment period,
the proposed amendment may be
examined and downloaded at this
Department of Justice website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed amendment upon written
request and payment of reproduction
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
Please enclose a check in the amount
of $3.25 (25 cents per page reproduction
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Susan M. Akers,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2018–04362 Filed 3–2–18; 8:45 am]
BILLING CODE 4410–15–P
OFFICE OF MANAGEMENT AND
BUDGET
[Docket ID OMB–OMB–2018–0001]
Draft 2017 Report to Congress on the
Benefits and Costs of Federal
Regulation and Agency Compliance
With the Unfunded Mandates Reform
Act
Office of Management and
Budget, Executive Office of the
President.
ACTION: Notice of availability and
request for comments.
AGENCY:
The Office of Management
and Budget (OMB) requests comments
on its Draft 2017 Report to Congress on
the Benefits and Costs of Federal
Regulations and Agency Compliance
with the Unfunded Mandates Reform
Act, available at: https://
www.whitehouse.gov/omb/informationregulatory-affairs/reports/. The Draft
Report is divided into two parts. Part I
contains three chapters. Chapter I
examines the benefits and costs of major
Federal regulations issued in fiscal year
2016. Chapter II discusses regulatory
impacts on State, Local, and tribal
governments, small business, wages and
employment, and economic growth.
Chapter III offers recommendations for
regulatory reform. Part II summarizes
agency compliance with the Unfunded
Mandates Reform Act. OMB requests
that comments be submitted
electronically to OMB by 4/06/18
through www.regulations.gov using
Docket ID OMB–OMB–2018–0001.
DATES: To ensure consideration of
comments as OMB prepares this Draft
Report for submission to Congress,
comments must be in writing and
received by 4/06/18.
ADDRESSES: Submit comments by one of
the following methods:
• www.regulations.go: Direct
comments to Docket ID OMB–OMB–
2018–0001.
• Fax: (202) 395–7285.
• Mail: Office of Information and
Regulatory Affairs, Office of
Management and Budget, New
Executive Office Building, Room 9235,
725 17th Street NW, Washington, DC
20503. To ensure that your comments
SUMMARY:
E:\FR\FM\05MRN1.SGM
05MRN1
]]>Agencies
[Federal Register Volume 83, Number 43 (Monday, March 5, 2018)]
[Notices]
[Pages 9337-9338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04407]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: PerkinElmer, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 4, 2018. Such
persons may also file a written request for a hearing on the
application on or before April 4, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement
[[Page 9338]]
Administration, Attn: Administrator, 8701 Morrissette Drive,
Springfield, Virginia 22152. All request for hearing should also be
sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ,
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug
Enforcement Administration, Attn: DEA Federal Register Representative/
DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
November 15, 2017, PerkinElmer, Inc., 549 Albany Street, Boston, MA
02118 applied to be registered as an importer of the following basic
classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Thebaine.............................. 9333 II
Lysergic acid diethylamide............ 7315 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk for manufacturing wherein the controlled substances will be
labeled with a radioactive tracer compound and sold for research
purposes to its customers. Thebaine (9333) will be used to manufacture
the derivative Diprenorphine.
Dated: February 26, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-04407 Filed 3-2-18; 8:45 am]
BILLING CODE 4410-09-P
